PDA Trains Kazakhstan Pharmaceutical Regulators

June 8, 2006
Pharmaceutical Technology Editors

ePT--the Electronic Newsletter of Pharmaceutical Technology

The Parenteral Drug Association (PDA, Bethesda, MD) finished the second stage of GMP training for representatives from the Republic of Kazakhstan?s Ministry of Health.

The Parenteral Drug Association (PDA, Bethesda, MD,  www.pda.org) finishedthe second stage of GMP training for representatives from the Republicof Kazakhstan's Ministry of Health. Over the next three years, PDAplans to train 100 delegates from Kazakhstan in an effort "to develop astronger, more informed pharmaceutical regulatory agency," PDA said inan official press release.

The training focuses on US and European regulations and requirementsnecessary for the review and approval of drugs and biologic products.Sessions also cover a range of drug development topics includingclinical trials, manufacturing, labeling, and advertising.


Related Content:

PharmTech News